Skip to main content

Table 1 Physiological and biochemical parameters of mice treated with vehicle or different doses of liraglutide

From: The role of endothelial nitric oxide in the anti-restenotic effects of liraglutide in a mouse model of restenosis

 

Vehicle

Liraglutide (nmol/kg/day)

5.7

17

107

Number

5

5

6

5

Food intake (g/day)

4.2 ± 0.2

4.1 ± 0.1

3.8 ± 0.2

4.2 ± 0.1

Water intake (g/day)

4.9 ± 0.2

5.2 ± 0.3

5.7 ± 0.1

4.9 ± 0.2

Initial BW (g)

21.6 ± 0.5

22.6 ± 0.4

22.9 ± 0.2

22.5 ± 0.5

Final BW (g)

22.5 ± 0.6

23.0 ± 0.8

24.8 ± 0.4

25.0 ± 0.4

Pulse rate (beats/min)

704 ± 15

709 ± 10

717 ± 14

707 ± 11

SBP (mmHg)

126 ± 3

123 ± 2

120 ± 5

125 ± 5

DBP (mmHg)

72 ± 7

72 ± 11

66 ± 11

82 ± 11

HbA1c (%)

5.1 ± 0.4

4.8 ± 0.2

4.7 ± 0.2

4.4 ± 0.1

FPG (mg/dL)

111 ± 28

98 ± 9

120 ± 12

112 ± 20

TC (mg/dL)

78 ± 10

67 ± 11

93 ± 5

91 ± 6

TG (mg/dL)

56 ± 3

51 ± 3

48 ± 3

61 ± 3

Active GLP-1 (pmol/L)

1.4 ± 0.2

2.2 ± 0.3

3.6 ± 0.8

8.4 ± 3.9*†

  1. Food and water intake were measured throughout the experimental period. The other parameters were evaluated at the end of the experiment, except for initial body weight (BW). Data are expressed as mean ± SEM
  2. SBP systolic blood pressure, DBP diastolic blood pressure, FPG fasting plasma glucose, TC total cholesterol, TG triglycerides, GLP-1 glucagon like peptide-1
  3. * p < 0.05 vs. vehicle; † p < 0.05 vs. liraglutide 5.7 nmol/kg/day